1. Home
  2. GRI vs EVTV Comparison

GRI vs EVTV Comparison

Compare GRI & EVTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$0.34

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Logo Envirotech Vehicles Inc.

EVTV

Envirotech Vehicles Inc.

HOLD

Current Price

$0.47

Market Cap

2.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRI
EVTV
Founded
2018
2012
Country
United States
United States
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
2.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
GRI
EVTV
Price
$0.34
$0.47
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$23.00
N/A
AVG Volume (30 Days)
1.4M
2.1M
Earning Date
11-14-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,696,856.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
113.69
52 Week Low
$0.31
$0.40
52 Week High
$15.64
$14.00

Technical Indicators

Market Signals
Indicator
GRI
EVTV
Relative Strength Index (RSI) 20.64 25.38
Support Level $0.33 $0.40
Resistance Level $2.17 $0.52
Average True Range (ATR) 0.13 0.14
MACD -0.07 -0.06
Stochastic Oscillator 1.86 7.69

Price Performance

Historical Comparison
GRI
EVTV

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

Share on Social Networks: